Corbus Pharmaceuticals Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.6M | $69.1M | $25.0M |
| FY2022 | $16.0M | $33.0M | $17.0M |
| FY2023 | $0 | $-6.9M | $13.7M |
| FY2024 | — | $142.4M | $17.2M |
| FY2025 | — | $147.5M | $28.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.6M | $69.1M | $25.0M |
| FY2022 | $16.0M | $33.0M | $17.0M |
| FY2023 | $0 | $-6.9M | $13.7M |
| FY2024 | — | $142.4M | $17.2M |
| FY2025 | — | $147.5M | $28.5M |